Medication info
Anatan 8 mg Tablet (Candesartan Cilexetil)

Anatan 8 mg Tablet (Candesartan Cilexetil)

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›8mg / 1 tablet
Manufacturer / importer
Ajou Pharmaceuticals Co., Ltd.
Appearance
White round tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201005235 · Approved 2010.08.31 · Insurance code 654003810

Summary

Main use
Essential hypertension and heart failure
Who takes it
Adults · Children
Adult dose
This medicine should be taken at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil taken orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure remains uncontrolled at this dose, another treatment should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: In patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those on hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks, taking the patient's tolerability into account, up to a maximum of 32 mg once daily. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No adjustment of the initial dose is necessary.
Child dose
1) Essential hypertension - Pediatric patients: The safety and efficacy have not been established in adolescents and children 18 years of age or younger. 2) Heart failure - Pediatric patients: The safety and efficacy have not been established in adolescents and children 18 years of age or younger.

Ingredients

Manufacturer
Ajou Pharmaceuticals Co., Ltd.

Efficacy & effects

Essential hypertension and heart failure

  • Essential hypertension
  • heart failure
  • left ventricular systolic dysfunction
  • decreased left ventricular ejection fraction
View approved original text

This medication is used to control blood pressure in hypertension, particularly essential hypertension. It is also helpful for patients with heart failure with decreased left ventricular function, especially those with low left ventricular ejection fraction and moderate to severe symptoms. It is particularly effective in patients who require additional treatment with an ACE inhibitor or cannot tolerate ACE inhibitors. This medication is very useful for reducing the burden on the heart and improving heart failure symptoms. Therefore, it is used for the treatment of essential hypertension and certain heart failure patients.

How to take

Adult dose

This medicine should be taken at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil taken orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure remains uncontrolled at this dose, another treatment should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: In patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those on hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks, taking the patient's tolerability into account, up to a maximum of 32 mg once daily. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No adjustment of the initial dose is necessary.

Child dose

1) Essential hypertension - Pediatric patients: The safety and efficacy have not been established in adolescents and children 18 years of age or younger. 2) Heart failure - Pediatric patients: The safety and efficacy have not been established in adolescents and children 18 years of age or younger.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so treatment should be stopped immediately upon confirmation of pregnancy. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication. Patients with allergies to this medication, severely impaired liver function, or those with hereditary lactose intolerance should also avoid it. Special caution is necessary for elderly patients, those with weaker kidney function, and patients with hyperkalemia, and it is important to regularly monitor potassium levels and kidney function with blood tests. This medication can cause side effects such as dizziness, back pain, and respiratory infections, and rarely symptoms like skin rashes, liver function abnormalities, or blood pressure drops. Heart failure patients should take this medication under the supervision of healthcare professionals due to the risk of blood pressure drops or worsening kidney function. There can be interactions if taken with other antihypertensive medications or diuretics, so consulting a physician is advised. Caution is required when driving or operating machinery, as dizziness may occur, and in case of overdose, immediate medical attention should be sought. The safety of this medication has not been established for children and adolescents, therefore, it is advisable not to use it in individuals under 18 years of age. When storing, keep it out of the reach of children, and do not transfer it to other containers.

Side effects

  • Dizziness
  • Low back pain
  • Respiratory infection
  • Upper respiratory infection
  • Pharyngitis
  • Rhinitis
  • Asthenia
  • Fever
  • Altered sensations
  • Dyspepsia
Show 70 more
  • Gastroenteritis
  • Tachycardia
  • Palpitations
  • Increased creatine kinase
  • Hyperglycemia
  • Hyperlipidemia
  • Hyperuricemia
  • Myalgia
  • Epistaxis
  • Anxiety
  • Depression
  • Somnolence
  • Dyspnea
  • Rash
  • Increased sweating
  • Hematuria
  • Hypotension
  • Hyperkalemia
  • Renal function impairment
  • Increased creatinine
  • Increased urea
  • Increased potassium
  • Fatigue
  • Peripheral edema
  • Chest pain
  • Headache
  • Bronchitis
  • Cough
  • Sinusitis
  • Nausea
  • Abdominal pain
  • Diarrhea
  • Vomiting
  • Arthralgia
  • Proteinuria
  • Leukopenia
  • Neutropenia
  • Agranulocytosis
  • Hyponatremia
  • Hypoglycemia
  • Intestinal vascular edema
  • Increased liver enzyme levels
  • Hepatitis
  • Elevated AST
  • Elevated ALT
  • Increased γ-GTP
  • Jaundice
  • Urticaria
  • Pruritus
  • Angioedema
  • Rhabdomyolysis
  • Acute renal failure
  • Interstitial pneumonia
  • Shock
  • Syncope
  • Loss of consciousness
  • Paralysis
  • Hypertonia
  • Facial flushing
  • Weight gain
  • Facial edema
  • Thirst
  • Sleep disorders
  • Decreased libido
  • Forgetfulness
  • Anorexia
  • Increased appetite
  • Tinnitus
  • Dysgeusia
  • Erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 degree and 30 degrees Celsius. Storing it this way helps to preserve the effectiveness of the medication.

Appearance and packaging

Appearance

White round tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.